AOD9604 2mg

AOD9604 (Anti-Obesity Drug) in a 2mg presentation is a next-generation peptide developed from the C-terminal region of human growth hormone (specifically fragment 177-191). Its mechanism of action focuses precisely on fat metabolism: it powerfully stimulates lipolysis (the breakdown of stored fat) and inhibits lipogenesis (the formation of new fatty acids), with a particular affinity for visceral and stubborn adipose tissue.

It is the ideal precision solution for body recomposition and definition protocols, offering the ability to significantly accelerate fat loss without altering blood glucose levels or affecting the endocrine axis or the IGF-1 receptor.